Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 43975-322

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 43975-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tolterodine-01 (D996a5c0 Db7e 4c41 9628 A2a4f9227af4 01)

Chemical structure of Tolterodine Tartrate, showing the molecular arrangement of the active ingredient Tolterodine combined with tartaric acid moiety.*

FDA Label Image

Image 01

Label for Tolterodine Tartrate Extended-release Capsules, 2 mg strength, showing a single capsule image marked 7L 013. The label indicates the product contains 90 capsules, is manufactured by Inventia Healthcare Limited (India), and distributed by ANI Pharmaceuticals, Inc. It includes storage instructions and barcodes for identification.*

FDA Label Image

Image 02

Label for Tolterodine Tartrate extended-release capsules, 4 mg strength. The label indicates 90 capsules in the package, manufactured by Inventia Healthcare Limited and distributed by ANI Pharmaceuticals, Inc. It includes storage instructions and a barcode with additional product codes and serial numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.